Pfizer Inc. Chief Executive Officer Ian Read said the company’s decision to sell or spin off its animal and nutritional health units hasn’t reached a conclusion.
Even in a high-stakes deal worth almost $120 billion, one that would create the world’s biggest drugmaker, the personal details matter.
Pfizer Inc. Chief Executive Officer Ian Read received a 44 percent raise in total compensation last year to $25 million in his new role as head of the world’s largest drugmaker, according to a regulatory filing.
Pfizer Inc. is back in the megamerger game.
"If we believe the value is still there and we believe, under our interpretation of these rules, there is still value, I see no reason why we would not be able to do an inversion."
- Ian Read on Oct 28, 2014